David G. Lowe, Ph.D. Managing Director, Skyline Ventures David G. Lowe, Ph.D. joined Skyline Ventures in 2002. Dr. Lowe serves on the boards of NimbleGen Systems, Inc., Applied Genetics Technologies Corporation, and Avidia, Inc. Prior to joining Skyline, Dr. Lowe spent 16 years at Genentech, Inc., where he led drug discovery activities in biologics and small molecule therapeutics, eventually as director of cardiovascular research. proteontherapeutics